Enoxaparin Dosing in Rhabdomyolysis
For immobilized patients with rhabdomyolysis requiring VTE prophylaxis, use enoxaparin 40 mg subcutaneously once daily, but reduce to 30 mg once daily if creatinine clearance is <30 mL/min, which is common in rhabdomyolysis due to acute kidney injury.
Rationale for VTE Prophylaxis in Rhabdomyolysis
Patients with rhabdomyolysis are at high risk for venous thromboembolism due to:
- Immobilization from muscle injury and weakness
- Dehydration which concentrates clotting factors
- Inflammatory state promoting hypercoagulability
The Canadian Stroke Best Practice guidelines 1 identify immobilized patients unable to move lower limbs independently as high-risk for VTE, making prophylaxis essential in rhabdomyolysis patients who are typically bedridden.
Standard Prophylactic Dosing
For patients with normal renal function (CrCl ≥30 mL/min):
- Enoxaparin 40 mg subcutaneously once daily 2
- This is the standard prophylactic dose for hospitalized medical patients
Critical Dose Adjustment in Renal Impairment
The most important consideration in rhabdomyolysis is renal function, as acute kidney injury is a hallmark complication. Multiple guidelines consistently recommend:
For CrCl <30 mL/min:
- Reduce enoxaparin to 30 mg once daily for prophylaxis 3
- This dose reduction is manufacturer-recommended and evidence-based 3
The rationale: Enoxaparin is renally cleared, and renal clearance decreases by 44% in severe renal impairment 3. Standard doses in severe renal failure increase bleeding risk 2-3 fold 3.
Alternative: Unfractionated Heparin
For patients with severe renal impairment (CrCl <30 mL/min), consider switching to unfractionated heparin (UFH) 5,000 units subcutaneously every 8-12 hours 4, 2. UFH is not renally cleared and may be safer in fluctuating renal function typical of rhabdomyolysis.
Monitoring Considerations
While routine anti-Xa monitoring is not required for prophylactic dosing, consider monitoring in rhabdomyolysis patients with:
- Rapidly changing renal function (common in rhabdomyolysis)
- Extreme body weights (<50 kg or >120 kg)
- CrCl 30-50 mL/min where some evidence suggests dose adjustment may be needed 3
If monitoring is performed, target prophylactic peak anti-Xa levels of 0.2-0.4 IU/mL measured 4 hours post-dose 3, 2.
Common Pitfalls to Avoid
Do not use standard 40 mg dosing in severe renal impairment - this significantly increases bleeding risk 3
Do not switch between enoxaparin and UFH back and forth - this increases bleeding complications 4
Reassess renal function daily in rhabdomyolysis - CrCl can change rapidly, requiring dose adjustments
Do not withhold prophylaxis unless active bleeding is present - the VTE risk in immobilized rhabdomyolysis patients is substantial 1
Consider mechanical prophylaxis (intermittent pneumatic compression) as adjunct or alternative if bleeding risk is prohibitive 1, 5
Duration of Prophylaxis
Continue prophylaxis until the patient is fully ambulatory or discharged from hospital 2. For patients remaining immobile beyond 30 days, continue pharmacological prophylaxis 1.